
Sign up to save your podcasts
Or


Dr. Timothy Smith joins us to talk about Zavegepant, a new option from the gepants class of medications that block CGRP. It is currently being studied as a nasal spray and oral gel cap for the acute and preventive treatment of migraine.
*The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD and the speaker do not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.
By Association of Migraine Disorders®4.7
2929 ratings
Dr. Timothy Smith joins us to talk about Zavegepant, a new option from the gepants class of medications that block CGRP. It is currently being studied as a nasal spray and oral gel cap for the acute and preventive treatment of migraine.
*The contents of this podcast are intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. AMD and the speaker do not recommend or endorse any specific course of treatment, products, procedures, opinions, or other information that may be mentioned. Reliance on any information provided by this content is solely at your own risk.

90,885 Listeners

2,558 Listeners

12,165 Listeners

2,511 Listeners

112,321 Listeners

6,441 Listeners

221 Listeners

24 Listeners

6,444 Listeners

28 Listeners

29,219 Listeners

20,517 Listeners

993 Listeners

7 Listeners

220 Listeners